A Pilot Factorial Trial of an Integrated Lifestyle Intervention

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Physical InactivityOverweight and Obesity
Interventions
BEHAVIORAL

Prevent T2

The PreventT2 curriculum is based on the original 2002 Diabetes Prevention Prevention (DPP) trial and follow-up studies. It promotes modest weight loss (5-7%) and increased physical activity through a lifestyle change program and also reflects new literature on self-efficacy, physical activity, and diet. There are 16 modules that will be delivered over 6 months. Participants will receive a calorie goal and be asked to count calories in order to reduce their caloric intake.

BEHAVIORAL

Move group-based classes

The Move physical activity support program group-based classes are based on Self-Determination Theory and encourage improvements in autonomous motivation for physical activity. These group-based classes are integrated within the Prevent T2 program curricula.

BEHAVIORAL

Fitness Membership

Participants will receive 6 months of the Peloton fitness membership. This includes access to livestream and on-demand fitness classes including walking, strength training, yoga, meditation, stretching, etc.

BEHAVIORAL

Mental Imagery

Participants will receive access to positive mental guided imagery recordings. Recordings describe a pleasant experience while walking and range from 2-8 minutes in duration.

BEHAVIORAL

Move 1:1 Support

Participants will meet individually with their class instructor to receive personalized recommendations on how to incorporate messages from the Move group-based classes into their daily lives. Sessions are based on Self-Determination Theory and will last approximately 45 minutes.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Colorado, Denver

OTHER